• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    The Carlyle Group Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    5/31/24 4:04:44 PM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email
    cg-20240529
    false000152716600015271662024-05-292024-05-290001527166us-gaap:CommonStockMember2024-05-292024-05-290001527166us-gaap:SubordinatedDebtMember2024-05-292024-05-29
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): May 29, 2024
    Carlyle-Logo-blue.jpg
    The Carlyle Group Inc.
    (Exact name of registrant as specified in its charter)
    Delaware
     
    001-35538
     
    45-2832612
    (State or Other Jurisdiction
    of Incorporation)
     
    (Commission
    File Number)
     
    (IRS Employer
    Identification No.)
    1001 Pennsylvania Avenue, NW
    Washington, DC 20004-2505
    (Address of Principal Executive Offices, Including Zip Code)
    (202) 729-5626
    (Registrant’s Telephone Number, Including Area Code)
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any
    of the following provisions (see General Instruction A.2. below):
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    Common Stock
    CG
    The Nasdaq Global Select Market
    4.625% Subordinated Notes due 2061 of Carlyle Finance
    L.L.C.
    CGABL
    The Nasdaq Global Select Market
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
    of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
    with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
    Item 5.02
    Departure of Directors or Certain Officers; Election of Directors; Appointment of
    Certain Officers; Compensatory Arrangements of Certain Officers.
    On May 29, 2024, The Carlyle Group Inc. (the “Company”) held its 2024 Annual Meeting of Shareholders (the “Annual
    Meeting”). As further described in Item 5.07 below, at the Annual Meeting, the Company’s shareholders approved The Carlyle
    Group Inc. Amended and Restated 2012 Equity Incentive Plan (the “Equity Incentive Plan”), which had been previously
    approved by the Company’s Board of Directors (the “Board”), subject to shareholder approval.
    A description of the Equity Incentive Plan is set forth in the section entitled “Item 4. Approval of The Carlyle Group Inc.
    Amended and Restated 2012 Equity Incentive Plan” starting on page 36 of the Company’s Definitive Proxy Statement on
    Schedule 14A, filed with the U.S. Securities and Exchange Commission on April 18, 2024 (the “Proxy Statement”), which is
    incorporated herein by reference. The description is qualified in its entirety by reference to the Equity Incentive Plan, a copy of
    which is attached hereto as Exhibit 10.1.
    Item 5.07
    Submission of Matters to a Vote of Security Holders.
    At the Annual Meeting, the Company’s shareholders considered six proposals, each of which is described in more detail in the
    Proxy Statement. The final voting results for each matter submitted to a vote of shareholders at the Annual Meeting were as
    follows:
    Item 1.  Election to Our Board of Three Director Nominees for a One-Year Term
    FOR
    WITHHELD
    BROKER NON-VOTES
    Daniel A. D’Aniello
    297,040,105
    12,516,890
    23,542,432
    Sharda Cherwoo
    308,518,313
    1,038,682
    23,542,432
    William J. Shaw
    302,172,377
    7,384,618
    23,542,432
    Item 2.  Ratification of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2024
    FOR
    AGAINST
    ABSTAIN
    BROKER NON-VOTES
    326,375,367
    6,583,018
    141,042
    —
    Item 3.  Management Proposal to Eliminate the Supermajority Vote Provision in Our Charter
    FOR
    AGAINST
    ABSTAIN
    BROKER NON-VOTES
    308,967,464
    502,455
    87,076
    23,542,432
    Item 4.  Approval of The Carlyle Group Inc. Amended and Restated 2012 Equity Incentive Plan
    FOR
    AGAINST
    ABSTAIN
    BROKER NON-VOTES
    253,091,280
    56,173,905
    291,810
    23,542,432
    Item 5.  Non-Binding Vote to Approve Named Executive Officer Compensation (“Say-on-Pay”)
    FOR
    AGAINST
    ABSTAIN
    BROKER NON-VOTES
    250,319,089
    58,881,055
    356,851
    23,542,432
    Item 6.  Shareholder Proposal to Adopt Improved Shareholder Right to Call a Special Shareholder Meeting
    FOR
    AGAINST
    ABSTAIN
    BROKER NON-VOTES
    119,111,471
    189,847,420
    598,104
    23,542,432
    Item 9.01
    Financial Statements and Exhibits.
    (d)Exhibits.
    Exhibit No.
     
     
    Description
    10.1+
    The Carlyle Group Inc. Amended and Restated 2012 Equity Incentive Plan.
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document).
    +
    Management contract or compensatory plan or arrangement in which directors and/or executive officers are eligible to
    participate.
    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on
    its behalf by the undersigned hereunto duly authorized.
     
     
    The Carlyle Group Inc.
    Date: May 31, 2024
     
     
    By:
     
    /s/ Jeffrey W. Ferguson
     
     
    Name:
     
    Jeffrey W. Ferguson
     
     
    Title:
     
    General Counsel
    Get the next $CG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    2/24/2026$67.00Outperform
    RBC Capital Mkts
    12/11/2025$74.00Buy
    UBS
    10/3/2025$74.00Outperform
    BMO Capital Markets
    7/10/2025$65.00Neutral → Buy
    Citigroup
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    More analyst ratings

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Carlyle Group with a new price target

    RBC Capital Mkts initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $67.00

    2/24/26 7:47:48 AM ET
    $CG
    Investment Managers
    Finance

    UBS resumed coverage on Carlyle Group with a new price target

    UBS resumed coverage of Carlyle Group with a rating of Buy and set a new price target of $74.00

    12/11/25 9:06:22 AM ET
    $CG
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Carlyle Group with a new price target

    BMO Capital Markets initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $74.00

    10/3/25 8:37:30 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carlyle to Acquire Majority Stake in MAI Capital Management

    The new investment strengthens MAI's capital base, supports advisors, and provides continuity for clients and teams MAI Capital Management ("MAI"), a registered investment advisor ("RIA") focused on empowering clients to simplify, protect, and grow their wealth, today announced that it has signed an agreement for funds managed by global investment firm Carlyle (NASDAQ:CG) to acquire a majority stake in the company, valuing it at more than $2.8 billion. Carlyle initially invested in MAI in 2021 through its investment in Galway Holdings, which acquired MAI that year, and will become the majority owner upon closing, with Galway Holdings, funds managed by Harvest Partners, LP ("Harvest Partne

    3/31/26 7:30:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Names New Senior Vice Presidents, Mohamed Karama and Nirav Dalal, to Drive Company Growth and Business Development

    MCLEAN, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Mohamed Karama has joined the company as Senior Vice President of Growth Acceleration and Performance, and Nirav Dalal has been promoted to Senior Vice President of Sales Leadership. These appointments advance Acentra Health's transformation initiatives and position the company for strategic growth. "As we continue transforming Acentra Health, we're investing in our growth engine," said Patty Obermaier, EVP, Chief Growth Offic

    3/25/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    SpendHound Reaches 1,000 Customers in only Two Years, Welcomes ZoomInfo as Enterprise Momentum Continues

    Rapid growth signals strong enterprise adoption and market momentum SpendHound, a subsidiary of YipitData and the #1 rated SaaS spend management platform on G2 that gives finance teams total visibility into software spend, today announced it has reached 1,000 customers in only two years, marking a major milestone in the company's breakout growth. The achievement is highlighted by the addition of ZoomInfo (NASDAQ:GTM), the leading go-to-market intelligence platform, as the company's 1,000th customer. "Reaching 1,000 customers is a huge milestone for our team and a clear signal of the trust the market has placed in us," said Vinicius Vacanti, Co-founder and CEO of YipitData. "Welcoming

    3/23/26 9:00:00 AM ET
    $CG
    $GTM
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Rubenstein David M.

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    3/20/26 5:34:13 PM ET
    $CG
    Investment Managers
    Finance

    Large owner Carlyle Group Inc. sold $1,070,339,440 worth of shares (26,105,840 units at $41.00) and disposed of 2,113,483 shares (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    3/12/26 4:30:20 PM ET
    $CG
    Investment Managers
    Finance

    Large owner Carlyle Group Inc. converted options into 9,297,883 shares and disposed of 9,297,883 units of Class B Common Stock (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    3/6/26 7:02:25 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by The Carlyle Group Inc.

    SCHEDULE 13G/A - Carlyle Group Inc. (0001527166) (Subject)

    3/26/26 4:44:46 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 10-K filed by The Carlyle Group Inc.

    10-K - Carlyle Group Inc. (0001527166) (Filer)

    2/27/26 4:13:57 PM ET
    $CG
    Investment Managers
    Finance

    The Carlyle Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    2/26/26 7:00:39 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Financials

    Live finance-specific insights

    View All

    Carlyle Presents Growth Outlook at 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) is announcing its growth outlook and financial objectives at the 2026 Shareholder Update, beginning today at 8:30 a.m. EST. The program will include presentations by senior leadership, followed by a Q&A session. Carlyle will announce three-year financial targets to be achieved by the end of 2028, including: FRE of $1.9+ billionInflows of $200+ billionDE per common share of $6.00+ Carlyle is also announcing that its Board of Directors has approved a new $2 billion share repurchase authorization. The authorization provides the firm with flexibility to repurchase shares as part of its disc

    2/26/26 7:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Secured Lending, Inc. Announces Financial Results For Fourth Quarter and Full Year Ended December 31, 2025, Declares First Quarter 2026 Dividend of $0.40 Per Common Share

    NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its fourth quarter and full year ended December 31, 2025. Alex Chi, CGBD's Chief Executive Officer, said, "As CGBD's newly appointed CEO, I look forward to continuing to build on Carlyle's strong track record and world-class platform. Building off record origination volume in the fourth quarter and full year 2025, we continue to expand our origination apparatus and are focused on further harnessing the full power of the OneCarlyle platform. The depth of our underwriting se

    2/24/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

    NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. (Eastern Time) on Wednesday, February 25, 2026 to announce its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its quarterly financial results on Tuesday, February 24, 2026. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc.     Carlyle Secured Lending, Inc. is a publicly traded (NASDA

    1/27/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    $CG
    Leadership Updates

    Live Leadership Updates

    View All

    Acentra Health Names New Senior Vice Presidents, Mohamed Karama and Nirav Dalal, to Drive Company Growth and Business Development

    MCLEAN, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Mohamed Karama has joined the company as Senior Vice President of Growth Acceleration and Performance, and Nirav Dalal has been promoted to Senior Vice President of Sales Leadership. These appointments advance Acentra Health's transformation initiatives and position the company for strategic growth. "As we continue transforming Acentra Health, we're investing in our growth engine," said Patty Obermaier, EVP, Chief Growth Offic

    3/25/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle to Host 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) announced today that it will host a Shareholder Update on Thursday, February 26, 2026. The Shareholder Update will include a series of presentations by the company's senior leadership team and will review Carlyle's growth outlook and financial objectives. Presentations will begin at 8:30 a.m. EST, followed by a Q&A session. Presentation materials and a live webcast will be posted on the day of the event and can be accessed on the Events & Presentations section of ir.carlyle.com. For those unable to join the live webcast, a replay will be available on the website following the event. Any

    2/2/26 8:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer

    MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

    1/27/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/15/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance